Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis

Clinical Immunology and Immunopathology

Volumn 78, Issue 1, 1996, Pages 61-69

  Biglino, Alberto ^a,c   Sinicco, Alessandro ^a   Forno, Brunella ^a   Pollono, Anna Maria ^a   Sciandra, Mauro ^a   Martini, Caterina ^b   Pich, Piergiorgio ^b   Gioannini, Paolo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b AMEDEO DI SAVOIA HOSPITAL   (Italy)

^c Asti Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029983475     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0009     Document Type: Article

References (54)

1. Bolognesi, D. P., and Schild, G. C., AIDS. 1990. Vaccines and immunology: Overview. AIDS 4(Suppl. 1P), 127-128, 1990.
2. Shearer, G. M., and Clerici, M., How human immunodeficiency virus ravages the immune system. Curr. Opin. Immunol. 4, 463-465, 1992.
3. Miedema, F., Immuno logical abnormalities in the natural history of HIV infection: Mechanisms and clinical relevance. Immunodefic. Rev. 3, 173-193, 1992.
4. Yarchoan, R., Mitsuya, H., and Broder, S., The immunology of HIV infection: Implications for therapy. AIDS Res. Hum. Retroviruses 8, 1023-1031, 1992.
5. Brenner, B. G., Gryllis, C., and Wainberg, M. A., Role of antibody-dependent cellular cytotoxicity and lymphokine-activated killer cells in AIDS and related diseases. J. Leukocyte Biol. 50, 628-640, 1991.
6. + T-cell subsets in symptomatic and asymptomatic HIV-1-infected individuals. AIDS Res. Hum. Retroviruses 7, 773-780, 1991.
7. Poli, G., and Fauci, A. S., The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res. Hum. Retroviruses 8, 191-197, 1992.
8. Cayota, A., Vuillier, F., Scott-Algara, D., Feuillie, V., and Dighiero, G., Impaired proliferative capacity and abnormal cytokine profile of naive and memory CD4 T cells from HIV-seropositive patients. Clin. Exp. Immunol. 88, 478-483, 1992.
9. Meyaard, L., Otto, S. A., Jonker, R. R., Mijnster, M. J., Keet, R. P., and Miedema, F., Programmed death of T-cells in HIV-1 infection. Science 257, 217-219, 1992.
10. Banda, N. K., Bernier, J., Kurahara, D. K., Kurrle, R., Haigwood, N., Sekaly, R. P., and Finkel, T. H., Crosslinking CD4 by human immunodeficiency virus gp120 primes T-cells for activation-induced apoptosis. J. Exp. Med. 176, 1099-1106, 1992.
11. Andersson, J., and Andersson, U., Characterization of cytokine production in infectious mononucleosis studied at a single-cell level in tonsil and peripheral blood. Clin. Exp. Immunol. 92, 7-13, 1993.
12. Linde, A., Andersson, B., Svenson, S. B., et al., Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J. Infect. Dis. 165, 994-1000, 1992.
13. Centers for Disease Control, Classification system for human T-lymphotropic virus type III lymphadenopathy-associated virus infection. MMWR 35, 334-339, 1986.
14. Gioannini, P., Sinicco, A., Cariti, G., Lucchini, A., Paggi, G., and Giachino, O., HIV infection acquired by a nurse. Eur. J. Epidemiol. 4, 119-120, 1988.
15. Biglino, A., Pugliese, A., Forno, B., Pollono, A. M., Busso, M., and Gioannini, P., Effects of long-term zidovudine treatment on cell-mediated immune response and lymphokine production. J. Acquired Immune Def. Syndr. 4, 261-266, 1991.
16. Godfrey, K., Comparing means of groups. In "Medical Uses of Statistics" (J. C. Bailar and F. Mosteller, Eds.), NEJM Books, Waltham, MA, 1986.
17. Glantz, S. A., "Primer of Biostatistics," 2nd ed., McGraw-Hill, New York, 1987.
18. Tindall, B., and Cooper, D. A., Primary HIV infection: host responses and intervention strategies. AIDS 5, 1-14, 1991.
19. Feinberg, J., The acute HIV seroconversion syndrome. Curr. Opin. Infect. Dis. 5, 221-225, 1992.
20. Sinicco, A., Biglino, A., Sciandra, M., Forno, B., Pollono, A. M., Raiteri, R., and Gioannini, P., Cytokine network and acute primary HIV-1 infection. AIDS 7, 1167-1172, 1993.
21. Sinicco, A., Palestro, G., Caramello, P., et al., Acute HIV-1 infection: clinical and biological study of 12 patients. J. Acquired Immune Defic. Syndr. 3, 260-265, 1990.
22. Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P., and Fauci, A. S., HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 326, 355-358, 1993.
23. Gruters, R. A., Terpstra, F. G., De Jong, R., Van Noesel, C. J., Van Lier, R. A., and Miedema, F., Selective loss of T cell functions in different stages of HIV infection: Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS. Eur. J. Immunol. 20, 1039-1044, 1990.
24. Ammar, A., Cibert, C., Bertoli, A. M., Tsilivakos, V., Jasmin, C., and Georgoulias, V., Biological and biochemical characterization of a factor produced spontaneously by adherent cells of human immunodeficiency virus-infected patients inhibiting interleukin-2 receptor alpha chain (Tac) expression on normal T cells. J. Clin. Invest. 87, 2048-2055, 1991.
25. Chirmule, N., Kalyanaraman, V. S., Oyaizu, N., Slade, H. B., and Pahwa, S., Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein GP120 of human immunodeficiency virus. Blood 75, 152-159, 1990.
26. Clerici, M., Stocks, N. I., Zajac, R. A., et al., Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature 339, 383-385, 1989.
27. Gaines, H., von Sydow, M. A. E., von Stedingk, L. V., et al., Immunological changes in primary HIV-1 infection. J. AIDS 4, 995-999, 1990.
28. Pedersen, C., Dickmeiss, E., Gaub, J., et al., T-cell subset alterations and lymphocyte responsiveness to mitogens and antigen during severe primary infection with HIV: A case series of seven consecutive HIV seroconverters. AIDS 4, 523-526, 1990.
29. Uehara, T., Miyawaki, T., Ohta, K., Tamaru, Y., Yokoi, T., Nakamura, S., and Taniguchi, N., Apoptotic cell death of primed CD45RO+ T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood 80, 452-458, 1992.
30. Luria, S., Chambers, I., and Berg, P., Expression of the type 1 human immunodeficiency virus NEF protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc. Natl. Acad. Sci. USA 88, 5326-5330, 1991.
31. Tyring, S. K., Cauda, R., Tumbarello, M., et al., Synthetic peptides corresponding to sequences in HIV envelope gp41 and gp120 enhance in vitro production of interleukin-1 and tumor necrosis factor but depressed production of interferon-alpha, interferon-gamma and interleukin-2. Virol. Immunol. 4, 33-42, 1991.
32. Akbar, A. N., Salmon, M., and Janossy, G., The synergy between naive and memory T-cells during activation. Immunol. Today 12, 184-189, 1991.
33. Rappocciolo, G., Toso, J. F., Torpey, D. J., III, Gupta, P., and Rinaldo, C. R., Jr., Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus. J. Clin. Microbiol. 27, 41-48, 1989.
34. Chehimi, J., Starr, S. E., Frank, I., et al., Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J. Exp. Med. 175, 789-796, 1992.
35. Tomkinson, B. E., Wagner, D. K., Nelson, D. L., and Sullivan, J. L., Activated lymphocytes during acute Epstein-Barr virus infection. J. Immunol. 139, 3802-3807, 1987.
36. Miyawaki, T., Kasahara, Y., Kanegane, H., Ohya, K., Yokoi, T., Yachie, A., and Taniguchi, N., Expression of CD45RO (UCHL1) by CD4+ and CD8+ T cells as a sign of in vivo activation in infectious mononucleosis. Clin. Exp. Immunol. 83, 447-451, 1991.
37. Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M., and Oldstone, B. A., Virus-specific cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68, 6103-6110, 1994.
38. Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., and Ho, D. D., Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68, 4650-4655, 1994.
39. Mackewicz, C. E., Yang, L. C., Lifson, J. D., and Levy, J. A., Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection. Lancet 344, 1671-1673, 1994.
40. Pantaleo, G., Demarest, J. F., Soudeyns, H., Graziosi, C., Denis, F., Adelsberger, J. W., Borrow, P., Saag, M. S., Shaw, G. M., Sekaly, R. P., and Fauci, A. S., Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 370, 463-467, 1994.
41. Kalams, S. A., Johnson, R. P., Trocha, A. K., Dynan, M. J., Ngo, H. S., D'Aquila, R. T., Kurnick, J. T., and Walker, B. D., Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179, 1261-1271, 1994.
42. Esser, R., von Briesen, H., Brugger, M., et al., Secretory repertoire of HIV-infected human monocytes/macrophages. Pathobiology 59, 219-222, 1991.
43. Wahl, L. M., Corcoran, M. L., Pyle, S. W., Arthur, L. O., Harel-Bellan, A., and Farrar, W. L., Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc. Natl. Acad. Sci. USA 86, 261-265, 1989.
44. Merrill, J. E., Koynayagi, Y., Zack, J., Thomas, L., Martin, F., and Chen, I. S., Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type I. J. Virol. 66, 2217-2225, 1992.
45. Kung, T. J., Castillo, M., Heard, P., Kerbacher, K., and Thomas, C. A., III, Subpopulations of CD8+ cytotoxic T cell precursors collaborate in the absence of conventional CD4+ helper T cells. J. Immunol. 146, 1783-1790, 1991.
46. Grant, M. D., Smail, F. M., and Rosenthal, K. L., Cytotoxic T-lymphocytes that kill autologous CD4+ lymphocytes are associated with CD4+ lymphocyte depletion in HIV-1 infection. J. Acquired Immune Defic. Syndr. 7, 571-579, 1994.
47. Ritter, M., Huber, C., Aubock, J., Pohl-Markl, H., Troppmair, J., Herold, M., Gachter, A., Nussbaumer, W., Bock, G., Nachbaur, D., et al., Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status. Immunology 81, 569-577, 1994.
48. Utermohlen, O., Tarnok, A., Bonig, L., and Lehmann-Grube, F., T lymphocyte-mediated antiviral immune responses in mice are diminished by treatment with monoclonal antibody directed against the interleukin-2 receptor. Eur. J. Immunol. 24, 3093-3099, 1994.
49. Sundstedt, A., Dohlsten, M., Hedlund, G., Hoiden, I., Bjorklund, M., and Kalland, T., Superantigens anergize cytokine production but not cytotoxicity in vivo. Immunology 82, 117-125, 1994.
50. Margolick, J. B., Scott, E. R., Odaka, N., and Saah, A. J., Flow cytometric analysis of γδ T cells and natural killer cells in HIV-1 infection. Clin. Immunol. Immunopathol. 58, 126-138, 1991.
51. Biglino, A., Forno, B., Pollono, A. M., Ghio, P., and Albera, C., Alveolar immune mediators in HIV-related pneumonia; different role of IL-2 and IL-1 in inducing lung damage. Chest 103, 439-444, 1993.
52. Odeh, M., The role of tumor necrosis factor-α in acquired immunodeficiency syndrome. J. Intern. Med. 228, 549-556, 1990.
53. Scott-Algara, D., Vuillier, F., Marasescu, M., de Saint Martin, J., and Dighiero, G., Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients. AIDS Res. Hum. Retroviruses 7, 381-386, 1991.
54. Moss, D. J., Burrows, S. R., Khanna, R., Misko, I. S., and Sculley, T. B., Immune surveillance against Epstein-Barr virus. Semin. Immunol. 4, 97-104, 1992.